Andere Sprachen AbbVie Inc. Buenos Aires S.E.

Aktien

Schlusskurs Buenos Aires S.E. Andere Börsenplätze 00:00:00 02.07.2024			% 5 Tage	% 1. Jan.
17 ^USD	-5.82%		-0.29%	+11.84%

01.07.	Merus ernennt neuen Chief Medical Officer	MT
01.07.	AbbVie sagt, dass Robert Michael die Rolle des CEO übernimmt	MT

AbbVie to Host Second-Quarter 2024 Earnings Conference Call	02.07.
Merus Names New Chief Medical Officer	01.07.
AbbVie : le nouveau directeur général prend ses fonctions	01.07.
AbbVie Says Robert Michael Assumes CEO Role	01.07.
Blackrock : Boeing, Meta...les valeurs à suivre aujourd'hui à Wall Street	01.07.
AbbVie : Robert A. Michael prend les commandes d’AbbVie	01.07.
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer	01.07.
AbbVie Announces Board Changes	01.07.
AbbVie - Introducing Alle Payment Plans, Powered by Cherry	28.06.
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	28.06.
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	28.06.
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28.06.
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28.06.
Health Care Stocks Fall With Broad Market -- Health Care Roundup	27.06.
Sector Update: Health Care Stocks Slipping Late Afternoon	27.06.
Sector Update: Health Care Stocks Decline in Afternoon Trading	27.06.
AbbVie : acquisition de Celsius pour 250 millions de dollars	27.06.
AbbVie Buys Celsius Therapeutics for $250 Million	27.06.
AbbVie Buys Celsius Therapeutics for $250 million	27.06.
AbbVie Buys Celsius Therapeutics for $250 million	27.06.

Keine Ergebnisse zu dieser Suche